Aurora Cannabis Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
4.8
Bearish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
ACB
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-23% margin).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $6.42 (+84.5%)
1 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
ACB
JNJ
—
Trailing P/E
26.3×
-31.6×
Forward P/E
17.9×
-22.5%
Profit Margin
21.8%
36.0%
Gross Margin
68.0%
-15.5%
ROE
26.4%
6.8%
Revenue Growth
9.9%
-94.7%
Earnings Growth
-52.9%
1.32
Beta
0.33
—
Price / Book
—
$206M
Market Cap
$546.9B
$3 – $7
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →